Panel Discussion

Early Diagnosis Through Predictive Biomarkers, NonInvasive Testing

In an excerpt from a panel discussion which took place at MedCity CONVERGE on July 11, 2018, Quanterix Chairman and CEO Kevin Hrusovsky joins other key innovators to discuss game-changing biotech advancements and the future of healthcare.